Efficacy of Second Forward-view Examination of Left Colon for Adenoma Detection During Colonoscopy

NCT05651893 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1516

Last updated 2023-04-06

No results posted yet for this study

Summary

The incidence of colorectal cancer in China is increasing year by year. Studies have shown that colorectal cancer is more common in the left colon,especially in the China. Our previous study also showed a higher rate of missed adenoma in the left colon than the right colon during colonoscopy. Additionally, prolonging withdrawal time could only improve the ADR of right colon, but had limited effect on the ADR of left colon in our previous research. Our aim is to evaluate the effect of a second forward view examination of the left colon on the detection of adenoma detection during colonoscopy.

Conditions

  • Colon Adenoma

Interventions

BEHAVIORAL

re-examination

During colonoscopy, the left colon was examined a second time in the forward view.

BEHAVIORAL

extended withdraw time

During colonoscopy, the left colon was examined with double basic withdrawal time in the forward view.

Sponsors & Collaborators

  • No.85 Hospital, Changning, Shanghai, China

    collaborator OTHER
  • Shanxi Provincial People's Hospital

    collaborator OTHER_GOV
  • The General Hospital of Eastern Theater Command

    collaborator OTHER
  • The Sixth Affiliated Hospital of Guangzhou Medical University

    collaborator OTHER
  • Fudan University

    collaborator OTHER
  • Kunshan Hospital of Traditional Chinese Medicine

    collaborator UNKNOWN
  • Ningjin County Hospital

    collaborator UNKNOWN
  • Qinghai People's Hospital

    collaborator OTHER
  • The First Affiliated Hospital of Yangtze University

    collaborator OTHER
  • Qujing NO.1 Hospital

    collaborator UNKNOWN
  • Jiangxi Provincial People's Hopital

    collaborator OTHER
  • Yueyang Central Hospital

    collaborator OTHER
  • The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine

    collaborator OTHER
  • The First People's Hospital of Changde City

    collaborator OTHER
  • Xuzhou Central Hospital

    collaborator OTHER
  • Wenzhou Central Hospital

    collaborator OTHER
  • Anhui Provincial Hospital

    collaborator OTHER_GOV
  • Jiangsu Provincial People's Hospital

    collaborator OTHER
  • Xiangya Hospital of Central South University

    collaborator OTHER
  • Changhai Hospital

    lead OTHER

Principal Investigators

  • Zhaoshen Li, MD · Changhai Hospital

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-01
Primary Completion
2024-01-31
Completion
2024-07-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05651893 on ClinicalTrials.gov